Levosimendan's effect on coronary artery grafts blood flow in patients with left ventricular dysfunction, assessment by transit time flow meter

Egyptian Journal of Anaesthesia

Volumn 27, Issue 1, 2011, Pages 45-53

  Asaad, Osama M ^a   Hanafy, Moataz S ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b Chest Diseases Hospital Kuwait   (Kuwait)

Author keywords

Coronary graft flow; Levosimendan; Transit time flow meter

Indexed keywords

LEVOSIMENDAN; MIDAZOLAM; MORPHINE; PROPOFOL; SUFENTANIL; THIAMINE; TROPONIN I;

ADULT; AGED; ANESTHESIA INDUCTION; ARTERY GRAFT; ARTICLE; BLOOD FLOWMETER; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART RATE; HUMAN; INTENSIVE CARE UNIT; INTERNAL MAMMARY ARTERY; LUNG VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; OXYGEN SATURATION; PULMONARY ARTERY OCCLUSION PRESSURE; RANDOMIZED CONTROLLED TRIAL; SAPHENOUS VEIN GRAFT; STABLE ANGINA PECTORIS; SYSTEMIC VASCULAR RESISTANCE; TRANSIT TIME FLOW METER; TREATMENT RESPONSE;

EID: 79960592037     PISSN: 11101849     EISSN: 16871804     Source Type: Journal    
DOI: 10.1016/j.egja.2010.12.001     Document Type: Article

References (28)

1. Levijoki J, Pollesello P, Kaivola J, et al. Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan: structure-response and binding analysis with analogs of Levosimendan. J Mol Cell Cardiol 2000;32:479-91.
2. Lilleberg J, Nieminem Akkila J, et al. Effects of a new calcium sensitizer levosimendan on hemodynamics coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J 1998;19:660-8. (Pubitemid 28224690)
3. Ukkonen H, Saraste M, Akkila J, et al. Myocardial efficiency during calcium sensitization with levosimendan: a noninvasive study with positron emission tomography and echocardiography in healthy volunteers. Clin Pharmacol Ther 1997;61:596-607. (Pubitemid 27261763)
4. Leonardo L, Paola P, Annalisa C, et al. Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunction. J Am Heart 2005;150(3):563-8.
5. Beldi G, Bosshard A, Hess OM, et al. Transit time flow measurement, experimental validation and comparison of three different systems. Ann Thorac Surg 2000;70:212-7. (Pubitemid 30485750)
6. Takami Y, Ina H. Relation of intraoperative flow measurement with postoperative quantitative angiographic assessment of coronary artery bypass grafting. Ann Thorac Surg 2001;72:1270-4. (Pubitemid 32938019)
7. Gabriele G, Marco P, Sergio C, et al. Predictive value of intraoperative transit-time flow measurement for short-term graft patency in coronary surgery. J Thorac Cardiovasc Surg 2006;132:468-74.
8. Ki-Bong K, Chang H, Cheong L. Prediction of graft flow impairment by intraoperative transit time flow measurement in off-pump coronary artery bypass using arterial grafts. Ann Thorac Surg 2005;80:594-8. (Pubitemid 41019486)
9. Lausten J, Pendersen EM, Terp K, et al. Validation of a new transit time ultrasound flow meter in man. Eur J Vasc Endovasc Surg 1996;12:91-6. (Pubitemid 26261564)
10. D'Ancona G, Karamanoukian H, Ricci M, et al. Graft revision after transit time flow measurements in off-pump coronary artery bypass grafting. Eur J Cardiothorac Surg 2000;17:287-93. (Pubitemid 30182632)
11. DiNardo JA, Bert A, Schwartz MJ, et al. Effects of vasoactive drugs on flows through left internal mammary artery and saphenous vein grafts in man. J Thorac Cardiovasc Surg 1991;1102:730-5.
12. Pataricza J, Krassoi I, Hohn J, et al. Functional role of potassium channels in the vasodilating mechanism of levosimendan in porcine isolated coronary artery. Cardiovasc Drugs Ther 2003;17:115-21. (Pubitemid 37174684)
13. Pataricza J, Hohn J, Petri A, et al. Comparison of the vasorelaxant effect of cromakalim and the new inodilator levosimendan in human isolated portal vein. J Pharm Pharmacol 2000;52:213-7. (Pubitemid 30125304)
14. Krassoi I, Pataricza J, Kun A, et al. Calcium-dependent vasorelaxant capacity of levosimendan in porcine and human epicardial coronary artery preparations. Cardiovasc Drugs Ther 2000;14:691-3. (Pubitemid 32217193)
15. Bowman P, Haikala H, Paul RJ. Levosimendan, a calcium sensitizer in cardiac Muscle induces relaxation in coronary smooth muscle through calcium desensitization. J Pharmacol Exp Ther 1999;288:316-25. (Pubitemid 29113506)
16. Maslow AD, Bert A, Slaiby J, et al. The effects of vasoactive agents on flow through saphenous vein grafts during lowerextremity peripheral vascular surgery. J Cardiothorac Vasc Anesth 2007;21:344-50. (Pubitemid 46829894)
17. Loesch A, Dashwood MR, Souza DS. Does the method of harvesting the saphenous vein for coronary artery bypass surgery affect venous smooth muscle cells?: iNOS immunolabelling and ultrastructural findings. Int J Surg 2006;4:20-9.
18. Tsui JC, Souza DS, Filbey D, et al. Preserved endothelial integrity and nitric oxide synthase in saphenous vein grafts harvested by a "no-touch" technique. Br J Surg 2001;88: 1209-15.
19. Souza DS, Johansson B, Bojö L, et al. Harvesting the saphenous vein with surrounding tissue for CABG provides long-term graft patency comparable to the left internal thoracic artery: results of a randomized longitudinal trial. J Thorac Cardiovasc Surg 2006;132:373-8.
20. Yokoshiki H, Katsube Y, Sunagawa M, et al. Levosimendan a novel Ca2+ sensitizer activates the glibenclamide-sensitive K+ channel in rat arterial myocytes. Eur J Pharmacol 1997;333:249-59. (Pubitemid 27387398)
21. Pieske B. Levosimendan in regional myocardial ischemia. Cardiovasc Drugs Ther 2002;16:379-81. (Pubitemid 36255737)
22. Luotalahti M, Lammintausta O, Ukkonen H, et al. Levosimendan, a calcium sensitizer and potassium channel opener is safe and improves left ventricular function in acute myocardial infarction. Circulation 1998;98(Suppl. I):105-6.
23. Moiseyev VS, Poder P, Adrejevs N, et al. Safety and efficacy of a novel calcium sensitizer levosimendan in patients with left ventricular failure due to an acute myocardial infarction. Eur Heart J 2002;23:1422-32. (Pubitemid 36285574)
24. Sonntag S, Sundberg S, Lehtonen LA, et al. The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia. J Am Coll Cardiol 2004;43:2177-82. (Pubitemid 38757582)
25. Végh Ágnes, Udvary Éva, Gy Julius. Effects of Simendan in a model of acute heart failure produced by severe regional myocardial ischaemia in dogs. J Mol Cell Cardiol 1992;24:S45.
26. Slawsky MT, Colucci WS, Gottlieb SS, et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Circulation 2000;102:2222-5.
27. Jaber SF, Koenig SC, BhaskerRao B, et al. Role of graft flow measurement technique in anastomotic quality assessment in minimally invasive CABG. Ann Thorac Surg 1998;66:1087-92. (Pubitemid 28462184)
28. D'Ancona G, Karamanoukian HL, Ricci M, Schmid S, et al. Graft revision after transit time flow measurement in off-pump coronary artery bypass grafting. Eur J Cardiothorac Surg 2000;17:287-93. (Pubitemid 30182632)